Abstract
Mo1260 Cysteamine Duodenal Ulcerogenic Potential Is Augmented With Stomach Lesions After Either L-NAME Administration or L-Arginine Administration. Counteraction by Stable Gastric Pentadecapeptide BPC 157
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have